Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
381
datasets available to search
ShareScore release 0.9.0
Dataset results
381 results for “acute respiratory distress syndrome”
Preventive Strategies in Acute Respiratory Distress Syndrome (ARDS)
ClinicalTrials.gov study NCT02070666. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Specific Elastance in Acute Lung Injury/Acute Respiratory Distress Syndrome (ALI/ARDS) Patients
ClinicalTrials.gov study NCT00143468. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PRONing to Facilitate Weaning From ECMO in Patients With Refractory Acute Respiratory Distress Syndrome
ClinicalTrials.gov study NCT04607551. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PaO2/FiO2*PEEP (P/FP) Ratio and Mortality in Acute Respiratory Distress Syndrome.
ClinicalTrials.gov study NCT03946150. IPD Sharing: NO. Countries: 1. Publications: 1.
Long-Term Results in Mechanically Ventilated Individuals With Acute Lung Injury/Acute Respiratory Distress Syndrome
ClinicalTrials.gov study NCT00300248. IPD Sharing: Not stated. Countries: 1. Publications: 19.
Discovery of New Early Detection Biomarkers of Acute Respiratory Distress Syndrome
ClinicalTrials.gov study NCT02625064. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease
ClinicalTrials.gov study NCT04335786. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pilot Study of Positive-End Expiratory Pressure in Acute Respiratory Distress Syndrome
ClinicalTrials.gov study NCT01119872. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Physiologic Effects of Continuous Positive Airway Pressure and High Flow Nasal Oxygenation in Patients with Acute Respiratory Distress Syndrome.
ClinicalTrials.gov study NCT06694311. IPD Sharing: YES. Countries: 1. Publications: 1.
Effect of Esmolol on Oxygenation Index in Patients With Acute Respiratory Distress Syndrome
ClinicalTrials.gov study NCT06013319. IPD Sharing: NO. Countries: 1. Publications: 4.
Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial
ClinicalTrials.gov study NCT04482621. IPD Sharing: NO. Countries: 1. Publications: 38.
Monitoring in Intensive Care Unit of Neuromuscular Blocking Agents Used for Acute Respiratory Distress Syndrome After Cardiothoracic Surgery
ClinicalTrials.gov study NCT02546947. IPD Sharing: NO. Countries: 1. Publications: 1.
Asynchrony During Mechanical Ventilation in Patients With Acute Respiratory Distress Syndrome
ClinicalTrials.gov study NCT02732041. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Biomarkers in Patients of Sepsis Complicated With Acute Respiratory Distress Syndrome (ARDS)
ClinicalTrials.gov study NCT04552821. IPD Sharing: NO. Countries: 1. Publications: 5.
Recruitment Assessment in Patients With Acute Respiratory Distress Syndrome and Covid-19
ClinicalTrials.gov study NCT05248243. IPD Sharing: NO. Countries: 1. Publications: 11.
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
ClinicalTrials.gov study NCT01506401. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Data from: Clinical characteristics and prognosis of drug-associated acute respiratory distress syndrome compared with non-drug-associated acute respiratory distress syndrome: a single-centre retrospective study in Japan
Objectives To report the clinical features and prognosis of drug-associatedacute respiratory distress syndrome (ARDS). Design A retrospective analysis of data collected during a prospective cohort study. Setting Intensive care unit in a teaching hospital. Participants A total of 197 Japanese patients with ARDS diagnosed by the Berlin definition who were admitted to the Division of Respiratory Medicine from October 2004 to December 2015 were enrolled in the study and were classified as two groups according to their causes: a drug-associated ARDS group (n=27) and a non-drug-associated ARDS group (n=170). Primary outcome measure is 28-day mortality, and the secondaryoutcome measure is ventilator-free days. Results The Acute Physiology and Chronic Health Evaluation II scores were significantly lower in the drug-associated ARDS group than in the non-drug-associated ARDS group (median (IQR): 18.0 (16.5–21.0) vs 23.0 (18.0–26.0), p<0.001), and the arterial oxygen tension/fractional inspired oxygen ratio was higher (148.0 (114.1–177.5) vs 101.0 (71.5–134.0), p=0.003). In the drug-associated ARDS group, although high-resolution CT scores indicative of the extent of fibroproliferation (301.6 (244.1–339.8) vs 208.3 (183.4–271.6), p<0.001), serum lactate dehydrogenase levels (477 (365–585) vs 322 (246–434), p=0.003) and the McCabe scores (score 1/2/3, n (%): 20 (74)/4 (15)/3 (11)vs154 (91)/7 (4)/9 (5), p=0.04) were significantly higher, ventilator weaning was earlier (p<0.001) and 28-day mortality was better (p=0.043). After adjusting for potentially confounding covariates, drug-associated ARDS group was associated with lower 28-day mortality (adjusted HR (HR) 0.275; 95% CI 0.106 to 0.711; p=0.008). Conclusions Although more severe lung damage with fibroproliferation was observed in patients with drug-associated ARDS, ventilator weaning was earlier, and their prognosis was better than the others. Further well-designed prospective studies are needed.
Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome
ClinicalTrials.gov study NCT04064684. IPD Sharing: NO. Countries: 1. Publications: 0.
Early Prone Positioning and Clinical Outcomes in Non-Intubated Acute Respiratory Distress Syndrome (ARDS) Patients
ClinicalTrials.gov study NCT07133022. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19
ClinicalTrials.gov study NCT04565249. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.